European Congress on Obesity

European Congress on Obesity
Name	European Congress on Obesity
Genre	Scientific conference
Frequency	Annual
Location	Varies
First	1993
Organiser	European Association for the Study of Obesity

European Congress on Obesity is the principal annual meeting organised by the European Association for the Study of Obesity bringing together clinicians, researchers, policymakers, and industry representatives to discuss advances in obesity prevention, treatment, and policy. The congress features peer‑reviewed symposia, workshops, poster sessions, and plenary lectures from leaders affiliated with institutions such as World Health Organization, European Commission, National Institutes of Health, and World Obesity Federation. Historically the event has influenced guidelines produced by bodies including National Institute for Health and Care Excellence, European Medicines Agency, and Organisation for Economic Co-operation and Development.

History

The congress originated from collaborative meetings between researchers at European Association for the Study of Obesity and national societies such as the British Obesity and Metabolic Surgery Society, German Obesity Society, and French Society for the Study of Obesity, formalising into an annual forum in the early 1990s alongside initiatives from World Health Organization Regional Office for Europe and advocacy by the Royal College of Physicians. Early editions featured keynote addresses by figures connected to Harvard Medical School, University of Cambridge, and Karolinska Institutet, reflecting ties to institutions like Imperial College London and University of Oxford. Over time the congress expanded content through partnerships with funders such as European Research Council and research networks including European Union Horizon 2020 consortia.

Organisation and governance

Governance is led by the European Association for the Study of Obesity Council and an elected Scientific Advisory Board composed of representatives from academic centres including Uppsala University, University of Barcelona, Heidelberg University Hospital, and University of Milan. Operational management frequently engages professional conference organisers with experience at venues like ExCeL London, Palais des Congrès de Paris, and Messe Berlin. Ethical oversight and conflicts of interest policies reference guidance from World Medical Association declarations and standards used by journals such as The Lancet, New England Journal of Medicine, and BMJ". Sponsorship and exhibition policies regulate participation from pharmaceutical companies including Novo Nordisk, Eli Lilly and Company, and medical device firms represented at trade exhibitions.

Scientific programme and topics

The scientific programme covers clinical research from investigators at centres like Mayo Clinic, Johns Hopkins Hospital, and Cleveland Clinic as well as basic science from laboratories at Max Planck Society, Pasteur Institute, and ETH Zurich. Sessions address bariatric surgery outcomes discussed by members of the International Federation for the Surgery of Obesity and Metabolic Disorders, pharmacotherapy trials for agents approved by European Medicines Agency, and behavioural interventions evaluated using methodologies from Cochrane Collaboration and CONSORT guidance. Public health and policy tracks engage stakeholders from European Centre for Disease Prevention and Control, World Health Organization, and United Nations Children's Fund, with topics ranging across genetics research influenced by Human Genome Project, metabolomics from European Molecular Biology Laboratory, and health economics drawing on work from Organisation for Economic Co-operation and Development.

Congress format and activities

Typical activities include plenary lectures by leaders affiliated with National Institutes of Health, roundtables convening representatives from European Commission, and skills workshops led by clinicians from Royal College of Surgeons and Association of British Clinical Diabetologists. The congress features competitive abstract-driven poster sessions judged by panels including editors from Obesity Reviews, International Journal of Obesity, and The Lancet Diabetes & Endocrinology. Technology showcases often highlight innovations by companies with ties to DARPA-funded initiatives, medical device demonstrations from Medtronic, and digital health platforms developed within Massachusetts Institute of Technology spinouts. Policy fora and stakeholder engagement events include participants from European Parliament committees and non-governmental organisations like European Public Health Alliance.

Attendees and membership

Attendees typically include clinicians from Royal College of Physicians of Edinburgh, researchers employed by Karolinska Institutet and University College London, representatives of patient advocacy groups such as European Patients' Forum, and industry delegates from Roche, Pfizer, and biotechnology startups spun out of Cambridge Biomedical Campus. Membership in the organising association overlaps with national societies including the Italian Society for Obesity and the Spanish Society for the Study of Obesity, while affiliate collaborations involve research networks funded by European Research Council grants and Horizon programmes.

Locations and dates

The congress is held annually at rotating European venues including Stockholm Waterfront Congress Centre, Milan Convention Centre, Vienna International Centre, Barcelona International Convention Centre, and Amsterdam RAI. Past editions have coincided with major policy moments involving European Commission Directorate-General for Health and Food Safety and convened during years when global conferences such as World Health Assembly and United Nations General Assembly debated noncommunicable disease strategies.

Impact and contributions to obesity research

The congress has catalysed multicentre collaborations producing trials registered with ClinicalTrials.gov and systematic reviews cited in guidance by National Institute for Health and Care Excellence and World Health Organization. Presentations have influenced clinical practice guidelines authored by societies such as the Endocrine Society and shaped regulatory decisions at European Medicines Agency. Research disseminated at the congress has contributed to advances in bariatric surgery techniques examined by American Society for Metabolic and Bariatric Surgery peers, metabolic pharmacotherapy evaluated by committees at Food and Drug Administration and European Medicines Agency, and public health interventions endorsed by World Obesity Federation and United Nations initiatives.

Category:Medical conferences